Mitaka, Japan

Naoyuki Ebisawa

This inventor holds 1 USPTO granted patent. Top assignee: Meiji Milk Products Company, Limited. Active years: 1983.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naoyuki Ebisawa. Retrieved from https://idiyas.com/inventor/naoyuki-ebisawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1983

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Naoyuki Ebisawa: Innovator in High Molecular Polysaccharides

Introduction

Naoyuki Ebisawa is a prominent inventor based in Mitaka, Japan. He is known for his significant contributions to the field of high molecular polysaccharides. His innovative work has led to the development of a new polysaccharide with potential applications in medicine.

Latest Patents

Ebisawa holds a patent for the high molecular polysaccharide MPS-80. This novel polysaccharide was obtained by culturing high molecular polysaccharide MPS-80-producing bacteria belonging to the genera Lactobacillus or Streptococcus. The MPS-80 polysaccharide exhibits an excellent anti-tumor effect, making it a promising candidate for use as an anti-tumor agent.

Career Highlights

Naoyuki Ebisawa is associated with Meiji Milk Products Company, Limited, where he continues to advance research in polysaccharides. His work has garnered attention for its potential health benefits and applications in the pharmaceutical industry.

Collaborations

Ebisawa has collaborated with notable colleagues, including Fumiyasu Tsuchiya and Kyushichi Miyazawa. Their combined expertise has contributed to the successful development of innovative products in the field.

Conclusion

Naoyuki Ebisawa's contributions to the field of high molecular polysaccharides highlight his role as an influential inventor. His work on MPS-80 demonstrates the potential for scientific advancements to impact health and medicine positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…